Auf geht's

Gesundheit Technologie

UnternehmenBranchen
UnternehmenBranchen

Schweizer Unternehmen, die Gesundheitstechnologien entwickeln

Die Entwicklung von Medizinprodukten, Diagnosegeräten und Softwareplattformen definiert den Sektor Gesundheitstechnologie. Die regulatorischen Zeitrahmen für Genehmigungen und Medicare-Vergütungsmodelle führen fortwährend eine Liquidität in diese Aktien ein. Aktuell dominiert Novartis AG das Handelsvolumen, während Inovio Pharmaceuticals, Inc. über die stärkste Performance in den letzten 24 Stunden verfügt. Die Tabelle unten enthält wichtige technische und fundamentale Metriken hierzu.
Symbol
Mkt. Cap
Preis
Änd %
Vol.
Rel. Vol.
KGV
EPS‑Verd.
TTM
EPS‑Verd. Wachstum
TTM YoY
Dividendenrendite %
TTM
Analystenrating
LLYEli Lilly and Company
1,09 T CHF1.180 CHF+23,56%10,3146,3825,44 CHF+57,99%0,47%
Starker Kauf
LLYEli Lilly and Company1,09 T CHF1.104,870 CHF−5,56%60,1343,4225,44 CHF+57,99%0,47%
Starker Kauf
JNJJohnson & Johnson543,72 B CHF227,679 CHF+3,11%120,8741,325,51 CHF−33,23%1,91%
Kauf
JNJ.USDJohnson & Johnson
543,72 B CHF261,25 USD0,00%1770,3539,635,51 CHF−36,38%1,91%
Kauf
4ABAbbVie, Inc.425,98 B CHF240,889 CHF+13,10%1,35 K9,2149,604,86 CHF+360,13%2,35%
Kauf
ABBVAbbVie, Inc.
425,98 B CHF236,65 CHF+1,24%200,3048,724,86 CHF+360,13%2,35%
Kauf
RORoche Holding Ltd
315,59 B CHF400,0 CHF+0,25%64,81 K2,4026,1015,33 CHF+30,49%2,69%
Kauf
RHORoche Holding Ltd315,59 B CHF405,099 CHF−0,76%150,7326,4315,33 CHF+30,49%2,69%
Kauf
ROPRoche Holding Ltd
315,59 B CHF390,3 CHF−0,36%1,44 M1,3025,4715,33 CHF+30,49%2,48%
Kauf
ROPRoche Holding Ltd315,59 B CHF386,324 CHF−1,65%3440,4125,2115,33 CHF+30,49%2,48%
Kauf
6MKMerck & Co., Inc.303,22 B CHF123,142 CHF+4,32%160,65150,440,82 CHF−86,41%2,26%
Kauf
MRK.USDMerck & Co., Inc.
303,22 B CHF151,22 USD0,00%1,24 K0,89154,430,82 CHF−87,05%2,26%
Kauf
NOTNovartis AG245,77 B CHF132,760 CHF−1,75%1270,2432,004,15 CHF−33,04%2,76%
Neutral
NOVNNovartis AG
245,77 B CHF133,08 CHF−0,78%4,01 M1,0032,074,15 CHF−33,04%2,76%
Neutral
NOVNEENovartis AG TEMP
245,77 B CHF132,56 CHF−1,88%130 K0,4531,954,15 CHF−33,04%2,76%
Kein Rating
ZEGAstraZeneca PLC239,39 B CHF155,416 CHF+1,57%2119,9126,625,84 CHF+18,22%1,70%
Kauf
TN8Thermo Fisher Scientific Inc.213,87 B CHF546,250 CHF−2,06%20,6534,4815,84 CHF+14,93%0,26%
Kauf
AMGAmgen Inc.211,44 B CHF388,337 CHF+1,70%90,7626,9414,41 CHF+39,89%2,08%
Neutral
GISGilead Sciences, Inc.176,9 B CHF134,099 CHF−5,57%200,15—−2,63 CHF−151,18%1,86%
Kauf
ABLAbbott Laboratories163,38 B CHF94,775 CHF+6,44%63130,0541,862,26 CHF−64,34%2,18%
Kauf
NVONovo Nordisk A/S Sponsored ADR Class B
DR
154,8 B CHF33,873 CHF+4,89%300,0310,213,32 CHF+21,39%2,92%
Neutral
NOVNovo Nordisk A/S Class B154,8 B CHF33,068 CHF+0,66%2480,1410,273,22 CHF+10,70%4,10%
Neutral
PFEPfizer Inc.143,45 B CHF23,577 CHF−5,69%4,31 K10,2840,340,58 CHF−57,23%5,59%
Neutral
IUI1Intuitive Surgical, Inc.136,6 B CHF375,728 CHF−4,11%251,5954,386,91 CHF+14,81%0,00%
Kauf
DAPDanaher Corporation135,1 B CHF187,464 CHF−1,94%1,65 K44,5936,725,11 CHF+31,91%0,65%
Kauf
VX1Vertex Pharmaceuticals Incorporated113,78 B CHF439,008 CHF−2,56%100,3033,7812,99 CHF+14,99%0,00%
Kauf
2M6Medtronic Plc109,74 B CHF85,457 CHF−0,24%40,1526,043,28 CHF+11,14%2,72%
Kauf
BRMBristol-Myers Squibb Company107,25 B CHF51,175 CHF+1,34%100,0313,573,77 CHF+59,93%3,93%
Kauf
SYKStryker Corporation105,69 B CHF257,002 CHF+2,09%70,1332,757,85 CHF+29,36%1,04%
Kauf
SANSanofi SA
92,58 B CHF67,98 CHF0,00%4500,1322,123,07 CHF−36,38%4,90%
Kauf
SNWSanofi SA92,58 B CHF77,442 CHF+6,14%4952,8225,203,07 CHF−36,38%4,90%
Kauf
0QFModerna, Inc.84,32 B CHF214,368 CHF+8,91%2,19 K10,49—−6,45 CHF−8,21%0,00%
Neutral
MRNAModerna, Inc.
84,32 B CHF161,56 CHF−20,41%8——−6,45 CHF−8,21%0,00%
Neutral
MRNA.USDModerna, Inc.
84,32 B CHF226,80 USD0,00%1,93 K1,55—−6,45 CHF−6,20%0,00%
Neutral
GS71GSK plc83,39 B CHF20,522 CHF+1,52%30,0417,341,18 CHF−17,14%3,60%
Neutral
ESLEssilorLuxottica SA80,36 B CHF175,776 CHF+9,63%1001,1335,584,94 CHF+2,56%2,12%
Kauf
EL1EssilorLuxottica SA
80,36 B CHF179,30 CHF0,00%1,73 K1,5736,294,94 CHF+2,56%2,12%
Kauf
MRKMerck KGaA60,03 B CHF138,411 CHF+6,22%2001,6827,505,03 CHF−18,23%1,46%
Kauf
BSXBoston Scientific Corporation54,29 B CHF37,640 CHF−0,39%5002,7419,061,97 CHF+32,59%0,00%
Kauf
CSJCSL Limited54,2 B CHF113,768 CHF−1,02%3861,17—−4,25 CHF−186,00%2,05%
Kauf
UNCUCB S.A.49,28 B CHF254,278 CHF+5,56%301,0324,3610,44 CHF+62,96%0,36%
Kauf
BAYNBayer AG
48,9 B CHF43,46 CHF0,00%6000,69—−1,63 CHF+49,77%0,20%
Kauf
BAYNBayer AG48,9 B CHF50,052 CHF−2,26%4800,51—−1,63 CHF+49,77%0,20%
Kauf
SHLSiemens Healthineers AG
45,93 B CHF41,12 CHF+11,14%250,0222,561,82 CHF+1,10%2,23%
Kauf
SHLSiemens Healthineers AG45,93 B CHF40,107 CHF−2,47%40,0622,011,82 CHF+1,10%2,23%
Kauf
GALDGalderma Group AG45,37 B CHF189,334 CHF−3,60%2130,8865,202,90 CHF+110,71%0,18%
Kauf
GALDGalderma Group AG
45,37 B CHF191,75 CHF−1,74%580,42 K1,0366,032,90 CHF+110,71%0,18%
Kauf
LONNLonza Group AG
45,09 B CHF663,4 CHF−1,34%212,06 K1,42—−1,55 CHF−115,18%0,76%
Kauf
LO3Lonza Group AG45,09 B CHF658,428 CHF−2,15%340,12—−1,55 CHF−115,18%0,76%
Kauf
IX1IDEXX Laboratories, Inc.44,99 B CHF561,726 CHF+28,10%1004,3745,2912,40 CHF+23,43%0,00%
Kauf
SDZSandoz Group Ltd
36,14 B CHF83,78 CHF+0,19%893 K0,6171,161,18 CHF+166,48%0,97%
Neutral
D8YSandoz Group Ltd36,14 B CHF83,263 CHF+0,29%1,07 K1,7070,721,18 CHF+166,48%0,97%
Neutral
RVMDRevolution Medicines, Inc.34,99 B CHF150,462 CHF−4,57%590,85—−7,13 CHF−99,36%0,00%
Starker Kauf
2U3Alcon AG31,62 B CHF60,879 CHF−3,84%1,21 K1,5858,721,04 CHF−44,92%0,44%
Kauf
ALCAlcon AG
31,62 B CHF61,30 CHF−2,36%1,23 M1,2759,121,04 CHF−44,92%0,44%
Kauf
ZOEZoetis, Inc. Class A30,13 B CHF65,569 CHF+0,36%100,2113,344,91 CHF+6,56%2,38%
Neutral
DC4DexCom, Inc.26,97 B CHF64,471 CHF−10,31%9367,8130,232,13 CHF+49,03%0,00%
Starker Kauf
IM8NInsmed Incorporated19,73 B CHF91,668 CHF−4,48%48——−2,35 CHF+52,19%0,00%
Starker Kauf
22UABioNTech SE Sponsored ADR
DR
18,62 B CHF70,648 CHF−5,05%330,78—−6,34 CHF−399,64%0,00%
Kauf
VTRSViatris, Inc.18,04 B CHF15,755 CHF+4,80%741,31—−0,29 CHF+87,49%2,50%
Kauf
DULAlnylam Pharmaceuticals, Inc17,64 B CHF138,579 CHF−27,27%1001,998,3716,55 CHF+8.543,33%0,00%
Kauf
ZBHZimmer Biomet Holdings, Inc.
17,17 B CHF76,0 CHF+1,33%340,4023,033,30 CHF+2,53%0,87%
Neutral
QS51Straumann Holding AG17,12 B CHF106,125 CHF−0,81%1030,6945,872,31 CHF−5,94%0,93%
Kauf
STMNStraumann Holding AG
17,12 B CHF104,50 CHF−1,28%363,31 K0,7945,172,31 CHF−5,94%0,93%
Kauf
SOONSonova Holding AG
16,68 B CHF288,0 CHF−1,44%197,29 K1,4239,887,22 CHF−20,12%1,62%
Neutral
PHBNSonova Holding AG16,68 B CHF287,176 CHF−1,86%1280,3439,777,22 CHF−20,12%1,62%
Neutral
EX9Exelixis, Inc.14,51 B CHF53,452 CHF+0,45%4001,2119,142,79 CHF+47,64%0,00%
Kauf
CBHDColoplast A/S Class B14,4 B CHF59,193 CHF+1,18%2 K11,2334,341,72 CHF−14,44%4,40%
Neutral
WDH1Demant A/S9,42 B CHF45,623 CHF+35,57%7 K40,7048,030,95 CHF−29,67%0,00%
Kauf
QGENQIAGEN NV8,58 B CHF41,772 CHF+40,91%100,1026,251,59 CHF+11,53%0,69%
Neutral
YDO1Madrigal Pharmaceuticals, Inc.7,6 B CHF358,641 CHF−0,42%120,38—−5,00 CHF+51,78%0,00%
Starker Kauf
HDP1Arrowhead Pharmaceuticals, Inc.7,12 B CHF50,112 CHF−7,82%2 K17,39—−1,81 CHF−80,90%0,00%
Starker Kauf
BANBBachem Holding AG Class B
6,12 B CHF79,70 CHF−0,06%58,18 K0,7840,101,99 CHF+11,05%1,10%
Kauf
BANBBachem Holding AG Class B6,12 B CHF78,273 CHF−3,74%120,1539,381,99 CHF+11,05%1,10%
Kauf
OWXYpsomed Holding AG5,28 B CHF387,308 CHF−4,22%10,0423,7616,30 CHF+154,29%1,10%
Kauf
YPSNYpsomed Holding AG
5,28 B CHF394,4 CHF−0,05%8,88 K0,7924,2016,30 CHF+154,29%1,10%
Kauf
1CGCRISPR Therapeutics AG4,11 B CHF40,056 CHF−2,75%6001,15—−3,97 CHF+10,71%0,00%
Kauf
SFZNSiegfried Holding AG3,38 B CHF71,467 CHF−3,66%320,1618,283,91 CHF+11,09%0,53%
Kauf
SFZNSiegfried Holding AG
3,38 B CHF72,00 CHF−1,37%104,69 K0,9418,413,91 CHF+11,09%0,53%
Kauf
IOVAIovance Biotherapeutics Inc3,22 B CHF7,100 CHF−40,91%300——−0,58 CHF+40,09%0,00%
Kauf
FIEFielmann Group AG3,19 B CHF36,668 CHF+1,13%1 K6,4915,752,33 CHF+23,36%3,38%
Kauf
TECNTecan Group AG
3,14 B CHF257,6 CHF−1,68%75,47 K0,91—−9,16 CHF−284,91%1,23%
Kauf
TENTecan Group AG3,14 B CHF253,933 CHF−4,60%561,10—−9,16 CHF−284,91%1,23%
Kauf
AFXCarl Zeiss Meditec AG2,94 B CHF32,719 CHF+1,21%1000,2132,701,00 CHF−41,01%1,54%
Verkauf
6MDMedacta Group SA2,48 B CHF106,788 CHF−10,36%1701,8129,853,58 CHF−20,27%0,89%
Kauf
MOVEMedacta Group SA
2,48 B CHF106,4 CHF−13,64%142,07 K4,9229,743,58 CHF−20,27%0,89%
Kauf
EZP1COMET Holding AG2,48 B CHF304,344 CHF+2,26%40,08132,652,29 CHF−54,20%0,16%
Starker Kauf
COTNCOMET Holding AG
2,48 B CHF298,0 CHF−0,13%57,39 K1,51129,882,29 CHF−54,20%0,16%
Starker Kauf
RXRXRecursion Pharmaceuticals, Inc. Class A1,98 B CHF3,117 CHF−4,45%4 K5,28—−0,75 CHF+48,25%0,00%
Kauf
METNMetall Zug AG Class B
1,8 B CHF835 CHF0,00%2282,26—−12,44 CHF+56,17%0,00%
Neutral
NDH1Metall Zug AG Class B1,8 B CHF820,202 CHF−0,27%20,21—−12,44 CHF+56,17%0,00%
Neutral
SKANSKAN Group AG
1,61 B CHF69,7 CHF−0,99%33,43 K0,9452,261,33 CHF+85,35%0,31%
Starker Kauf
7VGSKAN Group AG1,61 B CHF73,514 CHF+1,51%410,4055,121,33 CHF+85,35%0,31%
Starker Kauf
MEDMedartis Holding AG
1,51 B CHF109,6 CHF+2,05%14,27 K0,7891,441,20 CHF—0,00%
Starker Kauf
NVV1Novavax, Inc.1,44 B CHF8,008 CHF−3,65%5001,61—−1,23 CHF−168,74%0,00%
Kauf
PPPGNEPolyPeptide Group AG TEMP
1,36 B CHF44,00 CHF+0,34%1,97 K0,19108,860,40 CHF—0,00%
Kein Rating
8H0PolyPeptide Group AG1,36 B CHF43,866 CHF−0,37%4000,36108,530,40 CHF—0,00%
Neutral
PPGNPolyPeptide Group AG
1,36 B CHF40,05 CHF−1,11%21,45 K0,9799,080,40 CHF—0,00%
Neutral
IDIAIdorsia Ltd.
1,19 B CHF4,058 CHF−3,38%997,2 K1,24—−1,11 CHF−66,32%0,00%
Neutral
19TIdorsia Ltd.1,19 B CHF4,023 CHF−8,69%1000,08—−1,11 CHF−66,32%0,00%
Neutral